1. Short title This Act may be cited as the Monitoring and Obtaining Needed Information to Track Opioids Responsibly Act of 2017 or the MONITOR Act of 2017 . 2. Minimum requirements for State prescription drug monitoring programs Section 1003 of the 21st Century Cures Act ( 42 U.S.C. 290ee–3 note; relating to the Account for the State Response to the Opioid Abuse Crisis) is amended— (1) by redesignating subsection (f) as subsection (g); and (2) by inserting after subsection (e) the following: (f) Minimum requirements for State prescription drug monitoring programs (1) In general As a condition on receipt of a grant under this section, a State shall— (A) certify that the State has in effect a prescription drug monitoring program meeting the requirements of paragraph (2); or (B) agree to use a portion of the funds received through the grant to meet (or make progress in meeting) the requirements of paragraph (2). (2) Requirements To meet the requirements of this paragraph, a State’s prescription drug monitoring program must meet each of the following: (A) The program complies with the uniform electronic format specified by the Secretary under paragraph (3) for the reporting, sharing, and disclosure of information. (B) The program meets the standards of interoperability specified by the Secretary under paragraph (3). (C) The State requires dispensers to report to the program each dispensing in the State of a controlled substance listed in schedule II, III, or IV of section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ) no later than 1 business day after the controlled substance is dispensed to the patient. (D) The program makes reported information available to practitioners on a timely basis. (3) Uniform electronic format; interoperability (A) Establishment Not later than one year after the date of enactment of this Act, the Secretary shall specify for prescription drug monitoring programs— (i) a uniform electronic format for the reporting, sharing, and disclosure of information